Wenjuan Mei

Dr. Wenjuan Mei


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 January 2023 in Journal of Advanced Research
Verified
Journal Article
Open access
WMWenjuan Mei
Wenjuan Mei
YDYing Dong
Ying Dong
YGYan Gu
Yan Gu
AKAnil Kapoor
Anil Kapoor
XLXiaozeng Lin
Xiaozeng Lin
DTDamu Tang
Damu Tang
IQGAP3 possesses oncogenic actions; its impact on prostate cancer (PC) remains unclear. We will investigate IQGAP3's association with PC progression, key mechanisms, prognosis, and immune evasion. IQGAP3 expression in PC was examined by immunohistochemistry and using multiple datasets. IQGAP3 network was analyzed for pathway alterations and used to construct a multigene signature (SigIQGAP3NW). SigIQGAP3NW was characterized using LNCaP cell-derived castration-resistant PCs (CRPCs), analyzed for prognostic value in 26 human cancer types, and studied for association with immune evasion. Increases in IQGAP3 expression associated with PC tumorigenesis, tumor grade, metastasis, and p53 mutation. IQGAP3 correlative genes were dominantly involved in mitosis. IQGAP3 correlated with PLK1 and TOP2A expression at Spearman correlation/R = 0.89 (p ≤ 3.069e-169). Both correlations were enriched in advanced PCs and Taxane-treated CRPCs and occurred at high levels (R > 0.8) in multiple cancer types. SigIQGAP3NW effectively predicted cancer recurrence and poor prognosis in independent PC cohorts and across 26 cancer types. SigIQGAP3NW stratified PC recurrence after adjustment for age at diagnosis, grade, stage, and surgical margin. SigIQGAP3NW component genes were upregulated in PC, metastasis, LNCaP cell-produced CRPC, and showed an association with p53 mutation. SigIQGAP3NW correlated with immune cell infiltration, including Treg in PC and other cancers. RELT, a SigIQGAP3NW component gene, was associated with elevations of multiple immune checkpoints and the infiltration of Treg and myeloid-derived suppressor cells in PC and across cancer types. RELT and SigIQGAP3NW predict response to immune checkpoint blockade (ICB) therapy. In multiple cancers, IQGAP3 robustly correlates with PLK1 and TOP2A expression, and SigIQGAP3NW and/or RELT effectively predict mortality risk and/or resistance to ICB therapy. PLK1 and TOP2A inhibitors should be investigated for treating cancers with elevated IQGAP3 expression. SigIQGAP3NW and/or RELT can be developed for clinical applications in risk stratification and management of ICB therapy.

1 June 2018 in AME Medical Journal
Verified
Journal Article
Open access
PDF file
WMWenjuan Mei
Wenjuan Mei
YGYan Gu
Yan Gu
YJYanzhi Jiang
Yanzhi Jiang
PMPierre Major
Pierre Major
DTDamu Tang
Damu Tang

1 September 2018 in AME Medical Journal
Verified
Journal Article
Open access
PDF file
YGYan Gu
Yan Gu
XLXiaozeng Lin
Xiaozeng Lin
AKAnil Kapoor
Anil Kapoor
WMWenjuan Mei
Wenjuan Mei
DTDamu Tang
Damu Tang

1 January 2017 in Journal of Xiangya Medicine
Verified
Journal Article
Closed access
PDF file
WMWenjuan Mei
Wenjuan Mei
AKAnil Kapoor
Anil Kapoor
PMPierre Major
Pierre Major
BSBobby Shayegan
Bobby Shayegan
DTDamu Tang
Damu Tang